Immplacate

Immplacate is a preclinical-stage cell therapy company that is clinically developing educated mesenchymal cells (EMCs) for treatment of unwanted immune responses. Mesenchymal stromal cells (MSCs) are cells that can differentiate into a variety of other cell types.

Operating in health, Immplacate operates.

Immplacate is positioned in health, a segment that rewards a clear, focused offering.

Directory data places it at the Creative Destruction Lab alumni company stage.

Website: immplacatehealth.com/en/home